Kito Barrow

Kito Barrow serves as Interim Division Chair of Clinical Psychopharmacology and Adjunct Faculty in the Department of BA Psychology at The Chicago School's College of Undergraduate Studies, with appointments across Online and Dallas, TX campuses.

Her academic credentials include:

• Ph.D. in Pharmaceutical Sciences from Texas Tech University Health Sciences Center, Amarillo (2016)
• M.S. in Biotechnology from University of Texas at Dallas (2011)
• B.S. in Biology from University of Texas at Dallas (2008)

Dr. Barrow's research integrates Clinical Psychopharmacology with Cancer Therapeutics, specializing in selenium-based interventions for prostate cancer. Her work bridges pharmaceutical biochemistry and nutritional oncology, emphasizing translational applications of methylseleninic acid compounds in chemoprevention and redox modulation. This dual focus positions her at the intersection of mental health pharmacology and cancer intervention strategies.

Her scholarly output demonstrates consistent investigation into selenium metabolites' anticarcinogenic properties, with publications examining molecular mechanisms and clinical translation pathways. The 2015 research on mono-methyl selenium establishes foundational work connecting trace element biochemistry to therapeutic oncology applications.

As an educator committed to student development, Dr. Barrow teaches undergraduate and graduate courses while fostering critical thinking through active learning methodologies. Her professional affiliations include the American Association of Pharmaceutical Scientists, Association of Women in Science, and American Association for the Advancement of Science.